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Abstract
Herein, we have reviewed the role of glutamate, the major excitatory neurotransmitter in the brain, 
in a number of neurochemical, -physiological, and -behavioral processes mediating the 
development of alcohol dependence. The findings discussed include results from both preclinical 
as well as neuroimaging and postmortem clinical studies. Expression levels for a number of 
glutamate-associated genes and/or proteins are modulated by alcohol abuse and dependence. 
These changes in expression include metabotropic receptors and ionotropic receptor subunits as 
well as different glutamate transporters. Moreover, these changes in gene expression parallel the 
pharmacologic manipulation of these same receptors and transporters. Some of these gene 
expression changes may have predated alcohol abuse and dependence because a number of 
glutamate-associated polymorphisms are related to a genetic predisposition to develop alcohol 
dependence. Other glutamate-associated polymorphisms are linked to age at the onset of alcohol-
dependence and initial level of response/sensitivity to alcohol. Finally, findings of innate and/or 
ethanol-induced glutamate-associated gene expression differences/changes observed in a genetic 
animal model of alcoholism, the P rat, are summarized. Overall, the existing literature indicates 
that changes in glutamate receptors, transporters, enzymes, and scaffolding proteins are crucial for 
the development of alcohol dependence and there is a substantial genetic component to these 
effects. This indicates that continued research into the genetic underpinnings of these glutamate-
associated effects will provide important novel molecular targets for treating alcohol abuse and 
dependence.
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1. ALCOHOLISM AND GENETICS
Over half of adult Americans have a family history of alcoholism or alcohol (ethanol) abuse 
and one in four Americans have had an alcohol use disorder (AUD) during their lifetime, 
costing the US economy an estimated $225 billion per year (Research Society on 
Alcoholism).1,2 AUDs continue to be ranked as the third leading cause of preventable death 
by the Centers for Disease Control and Prevention.3 Moreover, research supports a causal 
relationship between AUDs and at least 50 different medical conditions.4–6
The well-documented familial incidence of alcoholism indicates that heredity contributes 
significantly to a predisposition toward, and the development of, AUDs.7–9 In fact, family 
history positive (FHP) individuals are at a three- to sevenfold increased risk to develop 
alcoholism, relative to those who are family history negative (FHN).10 This genetic proposal 
has been confirmed by multiple gene studies (e.g., the Collaborative Study On the Genetics 
of Alcoholism (COGA), the Study of Addiction: Genes and Environment (SAGE), and the 
European research project on risk-taking behavior in teenagers (IMAGEN)) examining the 
association between diagnostic criteria for alcohol dependence/addiction and the presence of 
single nucleotide polymorphisms (SNPs) in alcohol-dependent individuals.11–17
Similar to humans, different lines of heterogeneous stock rats display a wide-range of 
ethanol-consumption levels.18 The very early work by Williams and coworkers,19 as well as 
Mardones and coworkers,20 resulted in the hypothesis that ethanol intake in rodents is also 
under substantial genetic control. From their early work and that of four other international 
sites, bidirectional selective breeding has resulted in at least five high alcohol–consuming 
versus their respective low alcohol–consuming rat lines.21 One of these selectively bred high 
alcohol–consuming rat lines is the alcohol-preferring P rat. Essentially, starting from a 
closed colony of Wistar rats, the highest alcohol drinkers were mated together and the 
lowest alcohol drinkers were mated together, which resulted in the P and NP lines, 
respectively.21,22 The selectively bred alcohol-preferring P rat meets all of the criteria put 
forth for a valid animal model23,24 of alcoholism.21,22 It also meets the more recently 
proposed criteria including relapse-like,25 binge-like,21,22,26,27 and early/adolescent-onset of 
excessive drinking, which results in blood alcohol concentrations (BACs) greater than the 
threshold (80 mg%) of NIAAA’s28 definition for binge drinking.26,29 By the nature of 
selective breeding, P rats represent multigenerational FHP subjects and their counterparts, 
the selectively bred alcohol-nonpreferring NP rats, represent multigenerational-FHN 
individuals. Regarding the point about representing FHP individuals, the P rat has some 
neurochemical, neuro-physiological, and behavioral characteristics similar to those seen 
clinically in FHP individuals.21,26,30
Some of these neurochemical characteristics of P rats involve the gluta-matergic system and 
these findings parallel clinical findings in both FHP individuals and chronic alcoholics. The 
present minireview will focus on the central glutamatergic system and its role in alcohol 
dependence. The basic structure and function of the glutamatergic system will be outlined; 
as it pertains to its activity in the brain, its receptors, and transporters as well as the 
excitatory synapse. A summary of the existing literature on how ethanol affects the structure 
and function of the central glutamatergic system will be presented in the context of both 
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preclinical and clinical research. A synopsis of the genetic influence on the development 
and/or expression of alcohol dependence will be described. An overview of the current 
knowledge regarding how the ethanol–glutamate interaction affects gene and/or protein 
expression will be presented, again from both preclinical and clinical perspectives. This will 
be followed by a compilation of our findings with the P rat as it pertains to innate 
differences in gene and/or protein expression, relative to its NP counterpart, as well as 
ethanol’s modulation of gene and/or protein expression in subregions of the 
mesocorticolimbic reward circuitry. This minireview will then be concluded with some 
closing thoughts on some limitations observed in the existing literature.
2. CENTRAL GLUTAMATERGIC ACTIVITY
The amino acid glutamate is the primary excitatory neurotransmitter in the central nervous 
system (CNS). Therefore, it is not surprising that glutamate receptors are located throughout 
the brain (see Fig. 1 for glutamatergic projections). In addition, given the ubiquitous 
distribution of glutamate and its receptors, its function as the primary excitatory 
neurotransmitter is crucial for many processes, especially those mediating neuroplasticity, 
learning and memory.31–33 Glutamate interacts with both metabotropic mGlu1–mGlu8 
(Grm1–Grm8 = mGluR1–mGluR8) and ionotropic receptors, which include those that can 
bind to N-methyl-D-aspartate (NMDA) (subunits: GluN1 (Grin1 = NR1); GluN2a–GluN2d 
(Grin2a–Grin2d = Nr2a–Nr2d); GluN3a–GluN3b (Grin3a–Grin3b = NR3a–NR3b), those 
that can bind to α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) subunits: 
GluA1–GluA4 (Gria1–Gria4 = GluR1–GluR4) or kainite subunits GluK1–GluK4 (Grik1–
Grik4 = GluR5–GluR7 + KA1–KA2); these nomenclatures reflect IUPHAR, HUGO, and 
“old” symbols respectively.34–36 Due to glutamate’s role in excitotoxicity, extracellular 
glutamate must be tightly controlled.34,37,38 This is accomplished, for the most part, by 
multiple glutamate transporters.34 The human excitatory amino acid transporter 2 (EAAT2) 
and its rodent analog glutamate transporter 1 (GLT1) appear to be the main transporters 
performing this function centrally.34,37
2.1 Metabotropic Glutamate Receptors (Fig. 2)
The mGlu receptors are G-protein-coupled protein receptors (GPCRs) located at the 
neuronal synapse, extrasynaptically as well as on glial cells (Fig. 2). These receptors are 
divided into three groups. Group I mGluRs (mGlu1 and mGlu5) are predominately 
postsynaptic and engage in slow excitatory neurotransmission; Group II mGluRs (mGlu2 
and mGlu3) are predominately presynaptic, with some postsynaptic and glial localization 
(Fig. 2) where they engage in slow inhibitory neurotransmission; and Group III mGluRs 
(mGlu4, mGlu6, mGlu7, and mGlu8) are generally restricted to the presynaptic terminal 
and, like Group II mGluRs, engage in slow inhibitory neurotransmission. The 
mesocorticolimbic and associated reward circuitry express high levels of mGlu1, mGlu2, 
mGlu3, and/or mGlu5, notably in the Acb, caudate nucleus, cortex, lateral septum, dorsal 
striatum, amygdala, and hippocampus.39–43
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2.2 Ionotropic Glutamate Receptors (Fig. 2)
Ionotropic glutamate receptors are ligand-gated ion channels involved in fast excitatory 
transmission in the CNS. There are several types of glutamate ionotropic receptors including 
AMPA, kainate, and NMDA-receptor subunits. Most ionotropic glutamate receptors are 
located postsynaptically, although some are located presynaptically and on glia cells as well 
(Fig. 2). Similar to the mGlu receptors, they are found throughout the brain including 
cortical regions, hippocampus, amygdala, basal ganglia, midbrain, hind-brain, and brainstem 
nuclei.44–49 A recent functional addition to the iono-tropic glutamate receptors are the delta1 
and delta2 subunits symbolized by Glud1 and Glud2. In the past these subunits were 
considered orphans and not functional but more recent findings indicate that they are indeed 
functional, by modulating LTD and prepulse inhibition of the acoustic startle response 
(sensorimotor gating), and their localization is not restricted to the cerebellum but includes 
cortical and limbic regions as well.50–54
2.3 Glutamate Transporters and Carriers (Fig. 2)
As discussed earlier, excessive glutamate in the synapse (e.g., the addiction-related 
hyperglutamatergic state) can lead to excitotoxicity and neuronal death. Thus, glutamate 
uptake/transport from the synapse and perisynapse is required to prevent the plasticity 
associated with addiction to become excitotoxicity.34,38 There are several transporters that 
regulate extracellular glutamate levels including the EAAT1 (glutamate aspartate 
transporter: GLAST or Slc1a3), EAAT2 (GLT1), EAAT3 (excitatory amino acid carrier 1: 
EAAC1 or Slc1a1), EAAT4 (Slc1a6), and EAAT5; where EAAT indicates the human 
homolog.55–57 There are also intracellular vesicular glutamate transporters (VGLUT1–3 of 
the Slc17 family of genes) that mediate the uptake of glutamate into synaptic vesicles. 
Intracellular glutamate carriers, other than the vGLUTs, include the Slc25a family of genes. 
Since the NMDAR NR1 subunit contains the glycine-binding site, it is important to 
recognize the role of bidirectional glycine transporters (GlyT1 which is primarily glial and 
GlyT2 which is primarily neuronal) at the excitatory synapse (GlyTs are represented by gene 
families Slc6a and Slc7a). Given the increased interest in N-acetyl-cysteine’s role in mental 
health, it is equally important to recognize the cystine–glutamate exchanger’s (xCT = 
Slc7a11) role in reversing damage induced by excessive extracellular glutamate. The xCT, 
generally located on glial cells, takes up cystine and releases glutamate molecules. Cystine is 
then converted to cysteine, which is used to synthesize glutathione and other proteins. 
Glutathione is a key antioxidant and important in reversing neuronal damage induced by 
excitotoxicity and oxidative stress.58
2.4 Glutamate Synthesis and Metabolism (Fig. 2)
Another biologic method for preventing excessive glutamate in the synapse is glutamate’s 
synthesis from glutamine intracellularly.34 Glutamine can be transported into and out of the 
synapse without inducing neurotoxicity. The metabolism of glutamate to glutamine occurs 
primarily in glial cells via the enzyme glutamine synthetase. Glutamine is then transported 
(glutamine transporter (GlnT), which is common to both glia and neurons and encoded by 
the Slc38a gene family) out of the glial cell. In turn, glutamine is transported out of the 
perisynapse and into the excitatory presynaptic compartment. Glutamine is then converted to 
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glutamate by glutaminase and transported to the synaptic membrane, or shunted into GABA 
synthesis via glutamate decar-boxylase (GAD). Glutamate is also metabolized by glutamate 
dehydrogenase–yielding alpha-ketoglutarate, which enters the TCA/Krebs cycle.
2.5 Glutamate and the Postsynaptic Density (Fig. 2)
The postsynaptic density (PSD) is a cytoskeletal specialization that is located beneath the 
postsynaptic membrane and directly contiguous with the presyn-aptic “active zone” of 
excitatory synapses. Glutamate receptors, synaptic proteins, scaffolding proteins, kinases, 
and other downstream-signaling proteins are located within this PSD. There are several 
scaffolding proteins within the PSD including membrane-associated guanylate kinases 
(MAGUKs), Shanks, and Homers.59–61 Scaffolding proteins can be defined as molecules 
binding at least two other signaling proteins together. These scaffolding proteins are crucial 
for synaptic plasticity (e.g., learning and memory) by (1) acting as platforms where 
signaling molecules can assemble; (2) localizing signaling molecules at specific intracellular 
sites; (3) coordinating positive and negative feedback signals to modify intra- and extra-
cellular signaling pathways; as well as (4) protecting these signaling pathways from 
inactivation, generally by preventing and/or disrupting phosphorylation.62–64 In general, 
scaffolding proteins act as signaling proteins for neuromodulator receptors and anchor these 
receptors (e.g., glutamate receptors) to the synaptic membrane.65 Given their role in receptor 
anchoring, dysregulation of these scaffolding proteins can lead to a number of neurological 
diseases.66
MAGUKs are expressed widely throughout the central nervous system. They are the 
scaffolding proteins closest to the surface of the postsynaptic membrane and they contain 
multiple PDZ domains.67 The PSD-95 protein is one of the most studied MAGUK 
scaffolding proteins and is involved in postsynaptic stability as well as excitatory receptor 
insertion.68 PSD-95 binds to numerous proteins associated with AMPAR and NMDAR 
complexes. Schnell et al.69 found that interaction between PSD-95 and the AMPA receptor-
interacting protein, Stargazin, determines the density of AMPARs at the synapse and 
through this interaction can regulate synaptic maturation.70 The PSD-95 anchors NMDARs 
to the postsynaptic membrane and it acts as a signaling scaffold mediating the activation of 
neuronal nitric oxide synthase (nNOS) by calcium–calmodulin activity following, for 
example, entry of calcium through NMDAR channels.71 Differences between AMPA and 
NMDA receptors influence on synaptic events is due, in part, to their respective cytosolic C-
terminal binding sites to the PSD-95/ discs large/zona occludens-1 (PDZ) domain-
containing scaffolding proteins.72–74 The PDZ domain’s function is to regulate protein–
protein interactions by binding to the C-terminus of each respective target protein; thus, 
highlighting its crucial role in neuroplasticity, dendritic growth, and dendritic 
arborization.68,75
The ionotropic NMDA and AMPA receptors are primarily concentrated in the PSD but there 
are distinct differences in synaptic regulation of these receptors.76,77 Additionally, 
NMDARs initiate synaptic plasticity by interacting with other components of the PSD.78–82 
Similarly, AMPARs are involved in rapid synaptic transmission and these receptors cycle on 
and off in a manner tightly controlled by neuronal activity/plasticity in the PSD.78–82 The 
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recycling (i.e., insertion and removal) of these AMPARs at the synapse modulates synaptic 
efficiency and thus, like NMDARs, influence learning and memory.76,77
Considerable evidence indicates the crucial role of Shank and Homer proteins in 
neuroplasticity, as well as alcohol and drug dependence.83–89 Shank and the Homer 
scaffolding proteins are located deeper within the PSD than the MAGUKs (i.e., toward the 
cytoplasm).70 Three genes encode for Shank proteins (Shank1, Shank2, and Shank3) and 
Shank scaffolding proteins bind to neuroligins and neurexins, as well as NMDAR 
complexes in the PSD.70 Shanks are capable of binding other scaffolding molecules within 
the PSD (e.g., Homers) and thus are capable of linking mGlu receptors, as well as AMPA 
and kainate ionotropic receptors to NMDARs. Therefore, scaffolding proteins present in the 
PSD mediate a number of plasticity-associated events through reorganization of PSD-
associated proteins, regulation of membrane protein trafficking and activity, as well as the 
maintenance of associated epithelial cell polarity and morphology.90–92 Moreover, the 
connection between Shank proteins and neuroligins/neur-exins indicates that the PSD may 
bridge with the “active zone” of the presynaptic terminal. The Homer family of scaffolding 
proteins is encoded by 3 genes (Homer1, Homer2, and Homer3). Homer scaffolding proteins 
interact with the C-terminus of Group I mGluRs, bind to Shank/PSD-95/ NMDA-receptor 
complexes, and can also interact with a number of downstream effectors of mGlu1/5 
including: IP3 receptors, diacylglycerol lipase-2, and PI3K enhancer (PIKE). Homer 
proteins are best characterized for their role in regulating mGlu1/5 trafficking, PSD 
localization, and signaling of mGlu1/5 and NMDA receptors, but are also critical in the 
regulation of actin and dendritic morphology.93 Furthermore, through their ability to 
associate with Shank, Homers facilitate cross-talk between mGlu1/5 and NMDA receptors 
and the integration of their calcium-dependent intracel-lular events underpinning synaptic 
plasticity.94
3. CENTRAL GLUTAMATE ACTIVITY AND ALCOHOL DEPENDENCE
3.1 Alcohol’s Effects on Glutamate Activity and Extracellular Levels
Substantial preclinical evidence indicates that glutamatergic activity mediates natural as well 
as alcohol- and drug-associated reward through direct and indirect interactions with other 
neurotransmitter/neuromodulatory systems within the mesocorticolimbic, extended 
amygdala, and associated reward neurocircuitry (Fig. 1).95–102 A key hypothesis that has 
received considerable attention postulates that the mesocorticolimbic and extended 
amygdala reward circuits, in the presence of alcohol, lose homeostasis between excitatory 
and inhibitory transmission and revert to a hyperglutamatergic/hyper-excitatory state 
resulting in the development and expression of alcohol/drug dependence.37,98,102–107
In general, ethanol consumption and/or exposure to low or moderate doses of ethanol 
elevate glutamatergic transmission and/or extracellular levels of glutamate in the nucleus 
accumbens (Acb)108; Acb shell (AcbSh)88,89,109–111; basolateral amygdala (BLA)112; 
cortex113; Hippocampus114,115; ventral teg-mental area (VTA)116; and posterior VTA 
(pVTA).110,117 It has also been shown that genetics influence ethanol-induced increases in 
extracellular glutamate within the Acb and/or PFC, such that rats with a predisposition for 
higher ethanol intake (P and Lewis rats) display greater elevations in glutamate relative to 
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rats with a predisposition for lower ethanol intake (NP and F344 rats).118,119 Interestingly, 
similar relations have been observed between alcohol-preferring versus nonpreferring inbred 
strains of mice.86,120 In addition, these elevations in glutamatergic activity can be 
conditioned to the environment in which the animal had access to ethanol, with 
glutamatergic increases seen in the Acb core (AcbCo) or basolateral Amyg (BLA).103,121,122
A recent comprehensive preclinical study provides an excellent example of glutamate’s role 
in the development and expression of alcohol dependence.123 Griffin and coworkers123 
evaluated whether free-choice ethanol access would increase Acb extracellular glutamate 
levels and found that dependence-induced (chronic intermittent access via ethanol-vapor 
chambers) ethanol-drinking doubled Acb glutamate levels over those seen in nondependent 
mice. Moreover, these authors reported that this doubling of glutamate was observed a week 
later indicating that these increases in glutamate activity were not dependent upon ethanol 
withdrawal itself. Consistent with prior neuropharmacologic results in studies of low versus 
high alcohol–consuming inbred mice,120 Griffin etal.123 showed that pharmacologic 
elevation of glutamate in the Acb, with a pan-glutamate-reuptake inhibitor (Threo-beta-
benzyloxyaspartate, TBOA), increased the ethanol intake of nondependent mice to the levels 
observed in dependent animals, with TBOA also increasing ethanol intake further in the 
dependent mice. Also consistent with the results of Kapasova and Szumlinski,120 when the 
mGlu2/3 autoreceptor agonist LY379268 was microinjected into the Acb to lower glutamate 
levels, ethanol intake was decreased in both the dependent and nondependent mice.123 These 
latter results parallel earlier work indicating that manipulations of extracellular glutamate, 
including mGlu2/3 activation, actively regulate ethanol intake in multiple animal models of 
alcoholism (discussed later in the chapter).
Finally, evidence for altered glutamate neurotransmission within the previously mentioned 
brain regions, as well as the anterior cingulate cortex (ACC), has been reported in clinical 
studies of alcohol-dependent individuals as well.124–131 For example, a proton magnetic 
resonance spectroscopy (MRS) study examining the role of hippocampal glutamate in major 
depression and risky alcohol drinking revealed that elevated glutamate levels in the 
hippocampus were directly associated with both the presence of major depression and self-
reported risky drinking.132 These authors noted that the major depression and risky drinking 
group did not differ from the control group in age-of-first alcohol use, Alcohol Use 
Disorders Identification Test (AUDIT) survey scores or smoking behavior; but, this group 
did have significantly more FHP individuals (approximately six-fold) indicating a possible 
confound. Another recent MRS study provided support for differences in glutamate activity 
of FHP versus FHN individuals.133 These authors reported that glutamate/glutamine ratios 
increased significantly between adolescence and emerging adulthood in FHN, but not FHP, 
individuals. This suggests that having a familial history of AUDs may genetically predispose 
an individual for abnormal developmental changes in glutamatergic neurotransmission 
across periadolescence.133
3.2 Metabotropic Glutamate Receptors and Alcohol
It has been shown that ethanol-binge drinking by mice upregulates mGlu1/ 5-Homer2 
signaling in several mesocorticolimbic structures including the Acb83,84 and the central 
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amygdala (CeA)85 and activation of either or both of these Group I mGluRs is required for 
mice to manifest binge-drinking behavior.83–85
Several studies have examined the effects of mGlu5 antagonists on operant ethanol self-
administration behaviors in P rats as well. Systemic administration of the mGlu5 antagonist 
2-methyl-6-(phenylethynyl)pyridine (MPEP) can reduce operant ethanol self-
administration,134 reduce ethanol breakpoint without affecting sucrose breakpoint or 
locomotor activity,135 and block the repeated alcohol-deprivation effect (ADE).134 The 
effects of MPEP in rats were extended to mice by demonstrating that this mGlu5 antagonist 
interfered with the acquisition and maintenance of ethanol drinking by C57BL/6J mice as 
well,136,137 which appears to depend upon a protein kinase C-epsilon (PKC-epsilon) 
pathway.138 A subsequent study using P rats139 examined the effects of systemic MPEP on 
the extracellular signal-regulated kinase (ERK1/2) pathway,140 which is downstream of 
mGlu5 and implicated in addiction. MPEP attenuated cue-induced reinstatement of ethanol-
seeking behavior, which was associated with decreased phosphorylated (p)ERK1/2 
immunoreactivity (IR) in the BLA, but not CeA, and AcbSh, but not AcbCo.139 These 
findings support a role for ERK1/2 phosphorylation in the BLA and AcbSh in mediating 
cue-induced reinstatement of ethanol-seeking behavior. A third study from this laboratory141 
confirmed a role for mGlu5 within the AcbCo in ethanol self-administration; such that local 
application of MPEP into the AcbCo reduced ethanol operant responding without affecting 
locomotor activity, sucrose or water responding. In contrast, MPEP infused into the 
dorsomedial caudate nucleus or mPFC did not alter operant ethanol self-administration.141 
In a study that examined the effects of mGlu5 antagonist 3-[(2-methyl-1,3-tia-zol-4-
yl)ethynyl]-pyridine (MTEP) on ethanol self-administration by two high alcohol–consuming 
rat lines (inbred P (iP) and Fawn-Hooded (FH)) reported that MTEP significantly decreased 
intake.142 However, these authors also reported that MTEP induced mild sedative effects in 
iP but not FH rats. Together, these findings indicate that mGlu5 receptors play an important 
role in regulating different aspects of alcoholism-related behavior in both rat and mouse 
models.
Other mGluR ligands have also been tested for their effects on excessive ethanol drinking or 
ethanol reinforcement. Earlier studies revealed that systemic pretreatment with the selective 
mGlu1 antagonist, (−)-ethyl (7E)-7-hydroxyimino-1,7a-dihydrocyclopropa[b]chromene-1a-
carboxylate (CPCCOEt), produced inconsistent effects on operant ethanol self-
administration in P rats134 versus C57BL/6J mice,137 such that intra-Acb infusions of 
CPCCOEt were unable to alter binge drinking in mice.83 These inconsistent effects of 
CPCCOEt on measures of alcohol intake likely reflect its relative insolubility. For instance, 
the more soluble, highly selective, mGlu1 antagonist JNJ 16259685 lowers operant ethanol 
self-administration and ethanol breakpoint in P rats when administered systemically135,143 
and reduces binge drinking when infused into the AcbSh of mice.144 However, systemic JNJ 
16259685 pretreatment has nonselective effects in that it also reduces locomotor 
activity,135,143 which may reflect the high abundance of mGlu1 receptors in the cerebellum 
and their effects on its control of motor movement.134,135,143
Studies have also examined the effects of targeting mGlu2/3 receptors within the contexts of 
operant ethanol self-administration. When given systemically, the mGlu2/3 antagonist 
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LY341495 did not alter operant responding for ethanol by P rats,134 although systemic 
pretreatment with the mGlu2/3 receptor agonist LY404039 reduced ethanol-seeking and -
relapse-like behavior.145 However, these latter authors reported that LY404039 did not alter 
the maintenance of operant ethanol self-administration in these animals.145 Interestingly, the 
local application of the mGlu2/3 agonist LY379268 in the AcbCo was sufficient to reduce 
operant ethanol self-administration by P rats,141 in a manner akin to the aforementioned 
studies of mice drinking under free-access conditions in the home cage.120,123 While 
understudied, the effects of mGlu2/3 agonists appear to depend upon the route of 
administration or the experimental procedures employed. However, as observed with mGlu1 
antagonists,134,135,143 the effect of intra-AcbCo mGlu2/3 agonism on operant ethanol 
drinking by P rats is also not specific due to effects on locomotor activity.141 Other lines of 
evidence support an important role for mGlu2 receptors in drug addiction as well.97,102,146
3.3 Ionotropic Glutamate Receptors and Alcohol
As noted earlier, ionotropic glutamate receptors play an important part in the development 
of alcohol abuse and dependence, with many of ethanol’s effects mediated by these 
receptors. For instance, Enoch and coworkers147 as well as Jin and coworkers148 have 
reported that numerous ionotropic glutamate receptor subunit expression levels are 
significantly altered in chronic alcoholics and cocaine addicts, relative to control samples. 
Nevertheless, there has been limited behavioral–pharmacology research on the involvement 
of ionotropic receptors in excessive ethanol intake by P rats. Pretreatment with aniracetam, a 
selective positive allosteric modulator of AMPA receptors, increased operant responding for 
ethanol and cue-induced reinstatement of operant responding for ethanol by P rats, while not 
altering locomotor activity or operant responding for sucrose.149 These authors confirmed 
the involvement of AMPA receptors by demonstrating that the AMPA receptor antagonist 
6,7-dinitroquinoxaline-2,3-dione blocked aniracetam-induced increases in ethanol self-
administration. Besides the P rat, the selectively bred ALKO alcohol-accepting (high 
ethanol-consuming rat line from Finland) has also been used to assess the role of AMPA/
kainate receptors in excessive ethanol intake, with systemic administration of the antagonist 
CNQX significantly reducing operant ethanol-seeking behavior by these rats.150 In addition, 
systemic administration of the mixed NMDA/glycine receptor antagonist L-701,324 also 
significantly reduces operant ethanol-seeking behavior in AA rats.150 While MTEP is an 
mGlu5 receptor antagonist and decreases ethanol self-administration, it also decreases 
mRNA expression for both Glua2 and Glun1 in the cingulate cortex of iP and FH rats.142 
Thus, the effects of mGlu-receptor activity on ethanol intake are paralleled by its regulation 
of ionotropic glutamate receptor subunit gene expression underscoring the interaction of 
these two classes of glutamate receptors. Although there has been limited research on 
ionotropic glutamate receptors regarding alcohol- and/or drug-intake, -seeking, etc.151; there 
is clear evidence that NMDA and AMPA receptors are affected by ethanol, which in turn 
affects neuroplasticity, learning and memory.31,32,95,151,152
3.4 Glutamate Transporters/Carriers and Alcohol
Chronic ethanol-drinking or ethanol exposure significantly reduces glutamate uptake in the 
brain through downregulation of glutamate transporter, or antiporter, expression153–156 and 
reductions in glutamate transporter expression have been confirmed in postmortem 
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evaluation of brains from alcoholics.128 Recent studies have examined the effects of 
modulating GLT-1, glial EAAT2, and the cystine–glutamate antiporter (xCT) on ethanol 
intake. Ceftriaxone, a beta-lactam antibiotic, increases glutamate reuptake by upregulating 
GLT1 expression.157 Given the general hyperglutamatergic state in alcohol/drug 
dependence, it is not surprising that this compound also decreases ethanol consumption, 
ethanol dependence (ED)-associated withdrawal signs, and withdrawal-associated escalation 
of ethanol intake in P rats.158–162 These authors reported a consistent upregulation of GLT1 
expression in the Acb and mPFC, which was negatively associated with the observed 
reductions in ethanol consumption. Moreover, these authors have shown that ceftriaxone, or 
its analogs, significantly reduces ethanol intake and reverses chronic ethanol-induced 
downregulation of GLT1 expression in the mPFC, Acb, Amyg, and hippocampus, as well as 
reversing downregulation of xCT in some brain regions.153,163–166
Given that chronic ethanol induces excitotoxicity and oxidative stress, it is noteworthy that 
ethanol-induced increases in Slc7a11 (the protein product being xCT, the cystine–glutamate 
antiporter) are not dependent upon exci-totoxicity or oxidative stress.167 These authors 
reported that ethanol itself can inhibit octamer-binding transcription factor 1’s (OCT-1) 
repression of the Slc7a11 promoter in vitro, which in turn elevates Slc7a11 transcription. 
This increase in xCT would putatively increase the import of cystine into glial cells, where it 
would be converted to cysteine and subsequently into gluta-thione resulting in increased 
glutathione and decreased neurotoxicity.58 Regarding intracellular glutamate transport, an 
early study168 examined the effects of continuous ethanol exposure versus exposure 
interspersed with repeated deprivations on these vesicular glutamate transporters. These 
authors reported that repeated deprivations increased vGLUT2-immunos-tained terminals in 
the AcbSh compared to the water control group. However, ethanol exposure did not alter the 
level of vGLUT1-immunos-tained terminals in this brain region. These results suggest that 
the presence of multiple withdrawal episodes preferentially increases vGLUT2 expression in 
glutamate terminals in the AcbSh of P rats.168
3.5 Glutamate-Associated Enzyme Activity and Alcohol
Early work revealed that chronic ethanol exposure decreased glutamine synthetase while 
increasing glutamate and GAD in the cortex of rats.169 A more recent preclinical study 
found decreased GAD-67 expression levels, in the BLA, 2 months after 3 weeks of ethanol-
diet initiated in adulthood, but not adolescence.170 Another study reported that chronic 
ethanol consumption decreased glutamine synthetase in the striatum (dorsal vs. ventral was 
not delineated) but not cortex of rats.171 A contemporary study also reported reduced 
glutamine synthetase in the brain, although the area of the brain was not identified, after 
chronic ethanol consumption, which started at the beginning of adolescence.172 A 
postmortem study indicated that glutamine synthetase was downregulated in the 
hippocampus of alcoholics without hepatic pathology.173 These consistent reductions in 
glutamine synthetase following ethanol exposure or consumption suggest the presence of 
astro-cytic pathology and, by extension, increased neurotoxicity. Regarding glutamate 
dehydrogenase, which metabolizes glutamate; adolescent binge-like drinking by rats 
resulted in a 40% decrease in hippocampal glutamate dehydrogenase 1, which was not seen 
in rats that received the same protocol during adulthood.174 Given this finding, it is 
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noteworthy that ethanol inhibits NMDA excitation and LTP to a greater extent in 
hippocampal slices from adolescent versus adult rats.175,176 Therefore, significant 
differences in ethanol’s effects on glutamatergic activity occur across periadolescence and 
adulthood (see later in the chapter).
3.6 The Postsynaptic Density and Alcohol
Recent research indicates that alcohol and/or drugs of abuse have a profound developmental 
effect on the PSD as well174,177,178; such that, similar to earlier reports on the vulnerability 
of the adolescent hippocampus to alcohol and/or drug exposure,175,176 there is a differential 
effect of binge-like ethanol exposure between adolescent and adult rats. Risher et al.177 
reported that adolescent intermittent ethanol (AIE) exposure in rats reduced PSD-95 
expression levels in the hippocampus, leading to the retention of immature-like dendritic 
spine phenotypes into adulthood. There was also a reduction in the number of VGlut1/
PSD-95 and VGlut1/SAP102 (another MAGUK) colocalized synaptic puncta and these 
effects were driven by decreases in PSD-95 and SAP102 density with no effect on 
presynaptic VGlut1 expression levels.177 In contrast, chronic intermittent ethanol (CIE) 
during adulthood178 did not alter PSD-95 expression in the hippocampus as a whole. 
However, these authors indicated that adult CIE could alter dendritic complexity in a 
subregion-specific manner, with a partial return to basal levels after protracted 
abstinence.178 Taken together these studies suggest that the PSD-95, and glutamate activity, 
may be more vulnerable to ethanol-induced changes during adolescence than during 
adulthood and that adolescent ethanol-induced changes in PSD-95 may interfere with the 
maturation of dendritic spines. Similarly, considerable evidence indicates a crucial role for 
Shank and Homer proteins in neuroplasticity as well as alcohol and drug 
dependence.86–89,179 For example, significant increases in both AcbCo and CeA Homer2a/b 
expression levels were seen 24 h after the removal of ethanol from chronically drinking P 
rats.180
4. GLUTAMATE-ASSOCIATED GENETIC VARIATIONS AND ALCOHOLISM
An early Genome Wide Association Study (GWAS) followed by a Gene Set Enrichment 
Analysis (GSEA) found that when gene variations were analyzed for grouping, neuronal 
signaling genes dominated other associations with an individual’s level of response to 
alcohol and glutamate was the primary neurotransmitter system implicated.181 These authors 
also noted that FHP individuals show an altered level of response to alcohol and ketamine 
(an NMDA antagonist), thus confirming a genetic risk for alcoholism and altered 
glutamatergic function.181,182 Similarly, a pathway analysis of variants in 130 addiction-
related candidate genes confirmed a significant role for glutamate signaling in alcohol 
dependence, with the odds ratio of mGlu1-rs2300620 (>1.6) exceeding that of any other 
significant gene variant.183 A contemporary study using pathway analysis revealed the 
NMDA-dependent AMPA-trafficking cascade centered on the gene encoding the multiple 
PDZ domain protein (Mpdz) was significantly associated with alcohol dependence in a 
subset of the SAGE study.184
Regarding particular gene variants, polymorphisms of Glun2a, NR2a subunit of the NMDA 
receptor, are significantly associated with being an FHP individual, an early onset of risky 
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drinking during adolescence as well as the maximum number of drinks in adulthood, with 
this association having been replicated in a second large sample.185 A subsequent study also 
found that a polymorphism in the promoter region of Glun2a is significantly associated with 
alcohol dependence, with this finding replicated in a second sample.186 A variant of another 
ionotropic glutamate receptor subunit, Gluk3, was found to be associated with alcohol 
withdrawal–associated delirium tremens, but not seizures, in a German cohort.187 Another 
study reported that a polymorphism in Gluk1 is significantly associated with alcohol 
dependence in Caucasians, although many of the alcohol-dependent, but none of the control, 
subjects were polysubstance users, which may represent a confound in this study.188
Following earlier work indicating theta event-related oscillations (EROs) are associated with 
the P300 event-related potential (ERP), whose amplitude is negatively associated with 
FHP,189,190 a Family Based Association Test (FBAT) was carried out on a subset of the 
COGA sample.191 These authors reported that multiple polymorphisms of the mGlu8 gene 
are significantly associated with theta EROs and a genetic risk to develop alcoholism.191 A 
subsequent study by this group confirmed that polymorphisms of the mGlu8 gene are 
associated with a genetic risk to develop alcohol dependence.192 In another recent study, the 
mGlu3-rs6465084 polymorphism was found to be significantly associated with alcohol 
dependence in a male Han Chinese cohort.193
A recent study examining the association between polymorphisms in vesicular glutamate 
transporters and severe alcoholism in a female Swedish cohort indicated a nominally 
significant association with Slc17a6-rs2290045.194 A study evaluating associations between 
alcohol dependence and GAD genes (Gad1 and Gad2), the enzyme responsible for 
conversion of glutamate to GABA, in a subset of the Irish Affected Sib Pair Study of 
Alcohol Dependence sample reported that two polymorphisms in Gad1 were associated with 
initial sensitivity to alcohol and a different polymorphism in Gad1 was associated with age 
at alcohol dependence onset.195 An analysis of the relationship between Gad1 variants and 
alcohol dependence in an Italian cohort revealed that the Gad1-rs11542313 polymorphism 
was significant.196 An earlier study evaluating polymorphisms of Gad2 indicated that the 
functional promoter Gad2-243A>G variant was significantly associated with alcohol 
dependence in Russian but not European American males.197 A contemporary study found 
that three polymorphisms of Gad1, but no polymorphisms of Gad2, were significantly 
associated with alcohol dependence in Han Taiwanese men.198 In a recent genome-wide 
DNA methylation study, it was reported that methylation of Gad1 is significantly associated 
with alcohol dependence in a cohort of Han Chinese men, suggesting epigenetic effects of 
chronic alcohol abuse.199 These results indicate that polymorphisms in Gad1 are 
significantly associated with alcohol dependence, or related phenotypes, in multiple 
populations around the world.
5. ALCOHOL AND GLUTAMATE GENE EXPRESSION
Extending the previously mentioned behavioral pharmacologic and neuropharmacologic 
studies are the results of a very comprehensive study by Meinhardt and coworkers,200 
demonstrating that: (1) in ethanol-dependent rats, glutamate-related gene changes were 
primarily seen in the mPFC, rather than the Acb or amygdala; (2) within the mPFC of 
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ethanol-dependent rats, downregulation of the NMDA-receptor subunits Glun2a and 
Glun2b, as well as mGlu2, but not mGlu3, and egr1 (early growth response protein 1: 
Zif268, a transcription factor involved in neuroplasticity and vesicular exo-cytosis at 
excitatory synapses) were significant in the infralimbic mPFC only, with mGlu2 displaying 
the greatest reduction; (3) the AcbSh receives its glutamatergic projections primarily from 
the infralimbic mPFC, according to retrograde tracing, and these projection neurons 
displayed significant ethanol-dependence-associated downregulation of mGlu2, Egr2, and 
Egr4; (4) while basal glutamate in the AcbSh did not differ between ethanol-dependent and 
control rats, peripheral administration of the mGlu2/3 agonist LY379268 significantly 
reduced extracellular glutamate in the AcbSh of control but not ethanol-dependent rats, 
suggesting a downregulation of mGlu2/3 function; (5) ethanol-dependent rats displayed 
greater relapse (almost twice as many responses) and progressive ratio than controls; (6) 
lentivial knockdown of mGlu2 in the infralimbic mPFC significantly attenuated cue-induced 
reinstatement of responding in ethanol-dependent but not nondependent rats; (7) mGlu2 
knockdown rats did not differ from control rats in operant relapse responding, operant 
responding for sweetened condensed milk, or locomotor activity in an open-field test; and 
(8) a RT-qPCR analysis of postmortem ACC samples revealed that alcoholics had 
significantly less mGlu2 mRNA than their respective controls. An early postmortem study 
revealed that individuals who had abused nicotine, but not alcohol, displayed greater 
expression of Slc17a6 and Slc17a7 vesicular glutamate transporters in the VTA.201 
However, in individuals who abused both nicotine and alcohol, these increases in Slc17a6 
and Slc17a7 were significantly reduced.201
In another study, Enoch and coworkers147 reported that hippocampal glutamate receptor 
subunit gene expression levels differed between alcoholics, cocaine addicts, and healthy 
controls. Specifically, Glua4, Gluk3, and mGlu4 expression was significantly higher in 
alcoholics, relative to both controls and cocaine addicts; Glun2b expression was higher in 
both alcoholics and cocaine addicts, relative to control levels; and Glun2d and mGlu3 was 
upregulated in alcoholics while being downregulated in cocaine addicts, relative to control 
levels.147 Substantial changes of glutamate receptor subunit gene expression in the 
hippocampal dentate gyrus and to a lesser extent orbital frontal cortex, but not the dorsal-
lateral prefrontal cortex, of alcoholics versus healthy controls was confirmed in another 
recent postmortem study.148 In particular, the data from the dentate gyrus revealed that 
alcoholics had higher expression levels of Glua2, Glua3, Gluk2, Gluk3, Gluk5, Glun1, 
Glun2a, Glun2c, Glun2d, and Glun3a; whereas only Glun3a expression was higher than 
controls in the orbital frontal cortex.148
6. ALCOHOL-ASSOCIATED CHANGES IN GENE/PROTEIN EXPRESSION OF 
P RATS
An examination of protein expression changes in subregions of the Acb and Amyg of 
chronic ethanol-drinking P rats revealed at 24-h withdrawal that GluN2a expression levels 
were increased, whereas GluN2b expression levels were decreased in the AcbSh.180 These 
authors also reported that Homer2a/b, mGlu1, mGlu5, GluN2a, and GluN2b expression 
levels were all consistently increased in the AcbCo and CeA.180 To test the hypothesized 
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genetic role for the mGlu2 receptor in alcohol dependence, a recent RNA and exome 
sequencing study revealed that a SNP which creates a stop codon in the mGlu2 gene is 
present in P, but not NP, rats.202 This stop codon results in the absence of mGlu2 receptors, 
impaired gluta-matergic synaptic transmission, and altered levels of multiple genes 
associated with synaptic function. These authors also examined F2 rats from a PxNP–NPxP 
cross and found that mGlu2 expression levels were significantly and inversely related to 
ethanol consumption, with decreases in mGlu2 and mGlu2 receptor expression associated 
with significant increases in ethanol-drinking behavior.202 Similarly, mGlu2 knockout mice 
display significantly greater ethanol consumption and preference than their wild-type 
counterparts.202 As mGlu2 receptors function as autoreceptors, the results indicate an 
inverse relationship between mGlu2 gene/protein expression and ethanol intake, which is 
consistent with the aforementioned hypothesis that excessive drinking phenotypes are 
associated with a hyperglutamatergic state.
Our laboratories have published a number studies that examined central gene and/or protein 
expression profiles of P rats.180,203–215 Here we highlight alcohol-associated glutamate-
related genes whose expression levels have been identified as significantly changed by 
ethanol self-administration in P rats, or innately different between P and NP rats, in brain 
regions implicated in alcohol reward and reinforcement (Fig. 1).
6.1 Metabotropic Glutamate Receptor Expression Differences (Table 1)
A recent study revealed that periadolescent binge-ethanol consumption, using our drinking-
in-the-dark—multiple-scheduled-access model,27,29 resulted in a general elevation of mGlu1 
and mGlu4 (twice or three times that of controls, respectively) in the dorsal raphe nucleus 
(DRN) and mGlu7 (~1.4-fold increase) in the CeA.213 However, there was a significant 
decrease (~1.7-fold decrease) in mGlu6 expression within the DRN as well. Given that 
mGlu1, for the most part, is excitatory and the others inhibitory, this suggests a balance 
between ethanol-induced up- and downregulation of gene expression for these metabotropic 
receptors.
mGlu2 and mGlu3 expression levels were significantly lower in the AcbSh and CeA of adult 
ethanol-naive P versus NP rats.209,211 As discussed earlier, Zhou and coworkers202 reported 
a stop-codon polymorphism of mGlu2 in P, but not present in NP rats that appear to 
predispose them to high ethanol consumption. And, multiple studies134,135,141,143,145 have 
shown that mGlu2/3 agonists, presumably acting at the presynaptic autoreceptor, block 
ethanol-self-administration, -seeking, and -relapse behavior in P rats. Noteworthy is the fact 
that mGlu4, mGlu5, mGlu7, and mGlu8 (all are involved with inhibitory activity, generally 
at the presynaptic terminal) are also significantly lower in the AcbSh of P versus NP rats. 
Gene expression for only one mGluR, mGlu1, was ~1.4-fold higher in the AcbSh of P 
versus NP rats, which is a finding consistent with prior results from inbred C57BL/6J versus 
DBA2/J mice.86 Regarding the effects of ethanol, operant ethanol self-administration by 
adult P rats significantly reduced mGlu1 (~20% decrease) expression levels in the AcbSh, 
relative to ethanol-naive P rats.214 Given mGlu1’s basal elevation, relative to NP rats, it is 
possible that ethanol self-administration could reverse these levels; although, it is also 
possible for mGlu1 protein levels to be elevated by ethanol with mRNA levels responding in 
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the opposite direction. Regarding this hypothesis, our laboratory has shown that extended (6 
months) ethanol drinking by P rats does indeed increase mGlu1, and mGlu5, receptor 
protein expression in the AcbCo and CeA.180 Again, previous work with P rats found that an 
mGlu1 antagonist significantly reduced operant ethanol self-administration and breakpoint, 
although motor activity appeared to be affected as well.135,143 In general, these findings 
indicate that the effects of ethanol self-administration on Group1mGluR mRNA expression 
can be distinguished from effects upon protein expression and/or that different ethanol-
drinking experiences/ procedures elicit distinct changes in receptor mRNA/protein 
expression within Acb subregions, with more protracted drinking regimens eliciting changes 
within the more dorsal AcbCo.
Overall, adolescent binge-like ethanol drinking upregulated two of the three mGlu receptors 
identified as significantly changed. In the AcbSh of adult animals, P rats had only one of the 
seven mGlu genes identified as significantly greater than that seen in NP rats. It is 
noteworthy that the one gene that had higher expression levels in the AcbSh of adult P rats 
was downregulated following ethanol self-administration. Both genes identified as 
significantly different in the CeA of adult rats were Group II (mGlu2 and mGlu3) 
metabotropic receptors and were lower in P versus NP rats.
6.2 Ionotropic Glutamate Receptor Expression Differences (Table 2)
Ionotropic glutamate receptor subunits Glua3, Glua4, and Gluk3 were all elevated in the 
DRN following periadolescent binge-ethanol drinking, but not to the same extent as mGlu1 
and mGlu4.213 Gene expression changes were also observed for the “orphan” ionotropic 
glutamate delta receptor subunits Glud1 and Glud2. Regarding Glud2, there was a 3.5-fold 
increase in Glud2ip (delphilin) after periadolescent binge drinking as well;213 Glud2ip is a 
scaffolding protein for Glud2. To some extent, this parallels increases in expression levels of 
mGlu7, in the CeA, induced by periadolescent binge-ethanol drinking. In the periadolescent 
binge-drinking P rats, the GluN subunits were generally downregulated, with only the 
Glun2c subunit being upregulated.213
In adult P rats, whereas metabotropic glutamate receptor gene expression levels were 
consistently lower than those of NP rats; this was not true for Glua and Gluk gene 
expression,209,211 which was mixed. Glua1, Glua2, Glua3, and Gluk3 expression levels 
were all lower in the AcbSh of P versus NP rats; whereas Glua4 and Gluk1 expression levels 
were higher in the AcbSh of P versus NP rats.211 Ethanol-binge drinking by adult P rats 
reversed the ~30% deficit of Glua1 in the AcbSh through a 15% increase, relative to 
ethanol-naive controls.208 However, operant ethanol self-administration by adult P rats 
significantly reduced Glua2 and Glua3 expression levels, versus ethanol-naive controls, in 
the AcbSh.214 Thus, in spite of AcbSh deficits in Glua2 and Glua3 of adult P versus NP 
rats,211 operant ethanol self-administration appears to exacerbate this condition with further 
decreases in expression levels.
Surprisingly, despite no adult CeA Glua, Gluk, or Glun gene expression differences between 
P and NP rats; ethanol-binge drinking by adult P rats elevated Glua1, Glua2, Glua3, Gluk2, 
Gluk5, and Glun3a expression levels, with no significant downregulation of ionotropic 
glutamate receptor genes in this region.208
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Overall, periadolescent binge-like drinking decreased gene expression for certain NMDA 
receptor subunits in the DRN, but increased particular AMPA, delta, and kainate receptor 
subunits within this region as well. Ethanol self-administration by adult P rats did not 
downregulate any NMDA receptor subunits in the AcbSh but did upregulate an AMPA, 
delta, and NMDA-receptor subunit.
6.3 Expression Differences for Glutamate Transporters, Enzymes, and Postsynaptic 
Density (Table 3)
One of the most striking findings is that periadolescent binge-like drinking significantly 
downregulated gene expression for only three ancillary proteins (Mpp5, a MAGUK 
subfamily member, by ~30%; as well asVglut2 and Vglut3 by ~2-fold in the DRN); while 
upregulating expression levels for Homer3 and Slc1a1 in the CeA along with nine genes 
from the PSD (e.g., Homer3 ~4-fold and Tjp3 ~2.5-fold), as well as all three Shanks, two 
glutamate transporters (e.g., Slc1a6 ~3-fold), and two glutamate carriers in the DRN.213
In the adult AcbSh, P rats had lower gene expression of Homer1 than NP rats.211 However, 
operant self-administration of ethanol by adult P rats upregulated Homer1 by 3.5-fold in the 
AcbSh.214 These data are interesting as studies of rodents with free-access to 
ethanol83–85,89,180 or rodents injected repeatedly with alcohol86,88 have consistently 
detected increases in Homer2 protein expression within Acb and amygdala structures, 
without detecting significant changes in Homer1 protein expression. This raises the 
possibility that ethanol-induced changes in Homer1 mRNA/protein expression may depend 
upon nonpharmacologic factors associated with the act of ethanol taking, which has recently 
been demonstrated to be the case with respect to intravenous cocaine taking.216 Again in the 
AcbSh, P rats had higher expression levels of Shank1, whereas NP rats had higher 
expression levels of Shank2 and Shank3.211 Our data suggest a dissociation between the 
effects of home-cage ethanol drinking which decreased expression of Shank1 by ~15%204 as 
opposed to operant ethanol self-administration which increased expression levels of Shank1 
by ~20%214 in the AcbSh. Some support for this dissociation can be deduced from the fact 
that operant ethanol self-administration also increased Shank2 expression levels by ~ 20% in 
the AcbSh.214
In the adult CeA, operant ethanol self-administration upregulated Homer1 expression levels 
by over two-fold; although operant ethanol self-administration also downregulated Homer2 
expression by ~20%, relative to controls.214 This latter result is peculiar given that chronic 
free-choice access to ethanol upregulates CeA Homer2 protein expression in P rats180 and 
C57BL/6J mice;85 which, again, may be due to nonpharmacologic factors related to the 
operant-conditioning procedures employed in the mRNA study.
Glycine transporter expression levels in the adult AcbSh were higher and glutamate 
transporter expression levels were lower in P rats compared to NP rats.211 Additionally, 
whenever ethanol intake modified membrane glutamate transporter expression levels, once 
each in the adult or adolescent CeA and multiple times in the adolescent DRN, it was always 
for an increase relative to control levels.208,213 However, when examining vesicular 
glutamate transporter expression levels, Vglut1 was increased by five-fold, whereas Vglut2 
and Vglut3 were reduced by ~two-fold in the DRN following peri-adolescent binge-like 
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drinking.213 Also, in the adult AcbShVglut2 expression levels were more than two-fold 
higher than that seen in NP rats.211
In general, adolescent binge-like drinking upregulated 14 of the 17 glutamate ancillary genes 
identified as significantly changed, suggesting that ethanol induces substantial increases in 
DRN glutamatergic activity during this stage of development. Of the genes identified as 
significantly different between P and NP rats, in the AcbSh of adult animals, half were 
higher and half were lower. In the CeA (9 of 17) and VTA (4 of 5), adult P rats generally 
had lower expression levels of glutamate ancillary genes than their NP counterparts. 
Regarding ethanol exposure, 6 of the 10 genes identified as significantly different relative to 
ethanol-naive controls were upregulated in the AcbSh of adult P rats. In ethanol-drinking/
self-administering adult P rats, two of the five genes identified as significant in the CeA 
were downregulated. Overall, these findings of glutamate transporter and cytoskeleton/
scaffolding protein gene expression level changes induced by ethanol parallel the existing 
literature indicating that ethanol exposure alters glutamate clearance from the synapse and 
induces neuro-plastic changes in the PSD.
7. CONCLUSIONS
The findings discussed in this review include results from both pre-clinical as well as 
neuroimaging and postmortem clinical studies. Expression levels for a number of glutamate-
associated genes and/or proteins are modulated by alcohol abuse and dependence. These 
changes in expression include metabotropic receptors and ionotropic receptor subunits as 
well as different glutamate transporters. Moreover, these changes in gene expression parallel 
pharmacologic manipulation of these same receptors and transporters. Some of these gene 
expression changes may have predated alcohol abuse and dependence, because a number of 
glutamate-associated polymorphisms are related to a genetic predisposition to develop 
alcohol dependence. Other glutamate-associated polymorphisms have been linked to age at 
the onset of alcohol-dependence and/or initial level of response/sensitivity to alcohol. 
Finally, findings of innate and/or ethanol-induced glutamate-associated gene expression 
differences/changes observed in a genetic animal model of alcoholism, the P rat, are 
highlighted. Overall, the existing literature indicates that changes in receptors, transporters, 
enzymes, and scaffolding proteins are crucial for the development of alcohol dependence 
and there is a substantial genetic component to these effects.
This review reveals that there are presently key limitations to our understanding of 
glutamate’s role in the development of alcohol dependence and the impact that genetics has 
on this process. First, there are no studies examining glutamate-associated gene and/or 
protein expression changes across the juvenile, adolescent, emerging adult, and full adult 
stages of development. This information is crucial given the fact that the risky drinking age-
of-onset is inversely associated with the probability of developing alcohol dependence (i.e., 
earlier onset leads to higher risk of developing alcoholism). And, while there is some 
evidence for an association between being a FHP individual and initiating risky drinking at a 
younger age, findings comparing the effects of ethanol on glutamate function between FHP 
individuals/models and FHN individuals/models are very limited. Second, studies thus far 
have been limited to gross examinations of regions and/or subregions of major structures in 
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the central reward neu-rocircuitry. Also related to this point, a third limitation is the lack of 
publications examining multiple regions (i.e., putative circuits) within a single study. 
Despite these limitations, substantial progress has been made with new targets for 
medications development/screening identified, such as the GLT1/EAAT2 glutamate 
transporter or PKC-epsilon’s modulation of mGlu5 activity. Nevertheless, the research 
community still has much to do in unraveling the role of glutamate-associated genes in the 
development of alcohol dependence, especially as it relates to pharmacogenomics and 
personalized pharmacologic interventions.
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Figure 1. 
A simplified diagram depicting glutamatergic projections of the mesocorticolimbic, 
extended amygdala, and brainstem reward neurocircuitry. The online version includes color 
coding of these projections; with green representing the PFC/mPFC, red representing the 
amygdala, purple representing the hippocampus, blue representing the VTA, and gray 
representing the DRN.
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Figure 2. 
A simplified diagram of a prototypic glutamatergic synapse in the brain. The figure depicts 
some of the intra-, inter-, and extracellular activities of glutamate-associated plasticity. 
Abbreviations: AC, adenylate cyclase; AP2, adaptor protein 2; Arc, activity-regulated 
cytoskeleton-association protein; Asp, aspartate; GKAP/DAP1, disks large associated 
protein 1 (part of PSD); Gln or GluN, glutamine; GlnT, glutamine transporter; GLT, 
glutamate transporter; Glu, glutamate; Gly, glycine; GlyT, glycine transporter; LTD, long-
term depression; nNOS, neuronal nitric oxide synthase; Src, a tyrosine kinase; VDCC, 
voltage dependent calcium channel. Other abbreviations are in the text and tables.
Bell et al. Page 32
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bell et al. Page 33
Ta
bl
e 
1
M
et
ab
ot
ro
pi
c 
G
lu
ta
m
at
e 
Re
ce
pt
or
 (m
Gl
uR
) G
en
e (
m
G
lu
) E
xp
res
sio
n D
iff
ere
nc
es 
Be
tw
ee
n P
 an
d N
P R
ats
 (i
.e.
, F
old
-C
ha
ng
e (
F-
C)
 P 
vs
. N
P)
 or
 C
ha
ng
es 
In
du
ce
d 
by
 E
th
an
ol
 C
on
su
m
pt
io
n 
in
 P
 R
at
s, 
Re
la
tiv
e 
to
 E
th
an
ol
-N
ai
ve
 P
 R
at
s (
i.e
., F
-C
 E
tha
no
l (
E)
 vs
. C
on
tro
l (
C)
)
G
en
e I
D
G
en
e N
am
es
F-
C
 P
 v
s. 
N
P
F-
C
 E
 v
s. 
C
A
ge
 o
f R
at
Br
ai
n 
R
eg
io
n
m
G
lu
7
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
7 
(G
rm
7:
 
m
G
lu
R7
)
1.
37
A
do
le
sc
en
t
Ce
A
m
G
lu
1
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
1 
(G
rm
1:
 
m
G
lu
R1
)
2.
06
A
do
le
sc
en
t
D
R
N
m
G
lu
4
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
4 
(G
rm
4:
 
m
G
lu
R4
)
2.
98
A
do
le
sc
en
t
D
R
N
m
G
lu
6
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
6 
(G
rm
6:
 
m
G
lu
R6
)
−
1.
70
A
do
le
sc
en
t
D
R
N
m
G
lu
1
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
1 
(G
rm
1:
 
m
G
lu
R1
)
1.
39
A
du
lt
A
cb
Sh
m
G
lu
1
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
1 
(G
rm
1:
 
m
G
lu
R1
)
−
1.
19
A
du
lt
A
cb
Sh
m
G
lu
2
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
2 
(G
rm
2:
 
m
G
lu
R2
)
−
1.
46
A
du
lt
A
cb
Sh
m
G
lu
3
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
3 
(G
rm
3:
 
m
G
lu
R3
)
−
1.
22
A
du
lt
A
cb
Sh
m
G
lu
4
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
4 
(G
rm
4:
 
m
G
lu
R4
)
−
1.
39
A
du
lt
A
cb
Sh
m
G
lu
5
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
5 
(G
rm
5:
 
m
G
lu
R5
)
−
1.
30
A
du
lt
A
cb
Sh
m
G
lu
7
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
7 
(G
rm
7:
 
m
G
lu
R7
)
−
1.
38
A
du
lt
A
cb
Sh
m
G
lu
8
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
8 
(G
rm
8:
 
m
G
lu
R8
)
−
1.
33
A
du
lt
A
cb
Sh
m
G
lu
2
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
2 
(G
rm
2:
 
m
G
lu
R2
)
−
1.
84
A
du
lt
Ce
A
m
G
lu
3
G
lu
ta
m
at
e 
re
ce
pt
or
, m
et
ab
ot
ro
pi
c 
3 
(G
rm
3:
 
m
G
lu
R3
)
−
1.
24
A
du
lt
Ce
A
A
ge
 o
f r
at
 re
fe
rs
 to
 w
he
th
er
 th
e 
P 
ra
ts 
ha
d 
ac
ce
ss
 to
 e
th
an
ol
 d
ur
in
g 
(pe
ri-
)ad
ole
sce
nc
e (
po
stn
ata
l d
ay
s (
PN
Ds
) 3
0–
50
) o
r d
uri
ng
 ad
ult
ho
od
>P
ND
75
. B
rai
n r
eg
ion
s p
ub
lis
he
d t
hu
s f
ar:
 C
eA
, D
RN
, a
nd
 A
cb
Sh
. 
To
 fa
ci
lit
at
e 
di
sti
nc
tio
n 
be
tw
ee
n 
di
re
ct
io
ns
 o
f e
xp
re
ss
io
n 
(e.
g.,
 up
- v
s. 
do
wn
reg
ula
tio
n),
 do
wn
reg
ula
tio
n, 
or 
low
er 
lev
el 
F-
Cs
 ar
e i
n i
tal
ics
 an
d a
re 
be
low
 th
e f
ind
ing
s o
f u
pre
gu
lat
ion
 or
 hi
gh
er-
lev
el 
F-
Cs
 fo
r 
th
at
 a
ge
 a
nd
 b
ra
in
 re
gi
on
.
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bell et al. Page 34
Ta
bl
e 
2
Io
no
tro
pi
c 
G
lu
ta
m
at
e 
Re
ce
pt
or
 S
ub
un
it 
G
en
e 
Ex
pr
es
sio
n 
D
iff
er
en
ce
s B
et
w
ee
n 
P 
an
d 
N
P 
Ra
ts 
(i.
e.,
 Fo
ld-
Ch
an
ge
 (F
-C
) P
 vs
. N
P)
 or
 C
ha
ng
es 
Ind
uc
ed
 by
 
Et
ha
no
l C
on
su
m
pt
io
n 
in
 P
 R
at
s, 
Re
la
tiv
e 
to
 E
th
an
ol
-N
ai
ve
 P
 R
at
s (
i.e
., F
-C
 E
tha
no
l (
E)
 vs
. C
on
tro
l (
C)
)
G
en
e I
D
G
en
e N
am
es
F-
C
 P
 v
s. 
N
P
F-
C
 E
 v
s. 
C
A
ge
 o
f R
at
Br
ai
n 
R
eg
io
n
G
lu
a3
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
3:
 A
M
PA
3)
1.
29
A
do
le
sc
en
t
D
R
N
G
lu
a4
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
4:
 A
M
PA
4)
1.
31
A
do
le
sc
en
t
D
R
N
G
lu
d1
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rid
1:
 d
el
ta
1)
1.
20
A
do
le
sc
en
t
D
R
N
G
lu
d2
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rid
2:
 d
el
ta
2)
2.
31
A
do
le
sc
en
t
D
R
N
G
lu
a3
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rik
3:
 k
ai
na
te
3)
1.
35
A
do
le
sc
en
t
D
R
N
G
lu
n2
c
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
N
M
D
A
2c
 (G
rin
2c
: 
N
R2
c)
2.
61
A
do
le
sc
en
t
D
R
N
G
lu
n2
b
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c,
 N
M
D
A
2b
 (G
rin
2b
: 
N
R2
b)
−
1.
56
A
do
le
sc
en
t
D
R
N
G
lu
n2
d
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c,
 N
M
D
A
2d
 (G
rin
2d
: 
N
R2
d)
−
1.
40
A
do
le
sc
en
t
D
R
N
G
lu
n3
a
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c,
 N
M
D
A
3a
 (G
rin
3a
: 
N
R3
a)
−
1.
39
A
do
le
sc
en
t
D
R
N
G
lu
nl
1a
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c,
 N
M
D
A
1a
 li
ke
 (G
rin
l1
a:
 N
R1
a 
lik
e)
−
1.
32
A
do
le
sc
en
t
D
R
N
G
lu
a1
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
1:
 A
M
PA
1)
1.
15
A
du
lt
A
cb
Sh
G
lu
a4
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
4:
 A
M
PA
4)
1.
26
A
du
lt
A
cb
Sh
G
lu
d2
ip
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rid
2i
p:
 d
el
ta
2 
in
te
ra
ct
in
g 
pr
ot
ei
n)
3.
49
A
du
lt
A
cb
Sh
G
lu
k1
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rik
1:
 k
ai
na
te
1)
1.
73
A
du
lt
A
cb
Sh
G
lu
n1
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c,
 N
M
D
A
1 
(G
rin
1:
 N
R1
)
1.
09
A
du
lt
A
cb
Sh
G
lu
a1
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
1:
 A
M
PA
1)
−
1.
32
A
du
lt
A
cb
Sh
G
lu
a2
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
2:
 A
M
PA
2)
−
1.
21
A
du
lt
A
cb
Sh
G
lu
a2
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
2:
 A
M
PA
2)
−
1.
16
A
du
lt
A
cb
Sh
G
lu
a3
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
3:
 A
M
PA
3)
−
1.
52
A
du
lt
A
cb
Sh
G
lu
a3
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
3:
 A
M
PA
3)
−
1.
19
A
du
lt
A
cb
Sh
G
lu
k2
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rik
2:
 k
ai
na
te
2)
−
1.
33
A
du
lt
A
cb
Sh
G
lu
a1
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
1:
 A
M
PA
1)
1.
36
A
du
lt
Ce
A
G
lu
a2
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
2:
 A
M
PA
2)
1.
34
A
du
lt
Ce
A
G
lu
a3
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
ria
3:
 A
M
PA
3)
1.
57
A
du
lt
Ce
A
G
lu
k2
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rik
2:
 k
ai
na
te
2)
1.
14
A
du
lt
Ce
A
G
lu
k5
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c 
(G
rik
5:
 k
ai
na
te
5)
1.
30
A
du
lt
Ce
A
G
lu
n3
a
G
lu
ta
m
at
e 
re
ce
pt
or
, i
on
ot
ro
pi
c,
 N
M
D
A
3a
 (G
rin
3a
: 
N
R3
a)
1.
23
A
du
lt
Ce
A
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bell et al. Page 35
R
ef
er
 to
 T
ab
le
 1
 fo
r d
et
ai
ls.
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bell et al. Page 36
Ta
bl
e 
3
G
en
e 
Ex
pr
es
sio
n,
 fo
r A
nc
ill
ar
y 
Pr
ot
ei
ns
 o
f t
he
 E
xc
ita
to
ry
 S
yn
ap
se
, D
iff
er
en
ce
s B
et
w
ee
n 
P 
an
d 
N
P 
Ra
ts 
(i.
e.,
 Fo
ld-
Ch
an
ge
 (F
-C
) P
 vs
. N
P)
 or
 C
ha
ng
es 
In
du
ce
d 
by
 E
th
an
ol
 C
on
su
m
pt
io
n 
in
 P
 R
at
s, 
Re
la
tiv
e 
to
 E
th
an
ol
-N
ai
ve
 P
 R
at
s (
i.e
., F
-C
 E
tha
no
l (
E)
 vs
. C
on
tro
l (
C)
)
G
en
e I
D
G
en
e N
am
es
F-
C
 P
 v
s. 
N
P
F-
C
 E
 v
s. 
C
A
ge
 o
f R
at
Br
ai
n 
R
eg
io
n
H
om
er
3
H
om
er
 h
om
ol
og
 3
1.
15
A
do
le
sc
en
t
Ce
A
Sl
c1
a1
So
lu
te
 c
ar
rie
r f
am
ily
 1
 (n
eu
ron
al 
hig
h a
ffi
nit
y g
lut
am
ate
 tr
an
sp
ort
er)
, m
em
be
r 1
1.
14
A
do
le
sc
en
t
Ce
A
D
lg
1/
Sa
p9
7
D
isc
s, 
la
rg
e 
ho
m
ol
og
 1
 (S
ap
97
, A
M
PA
R 
tra
ffi
ck
ing
)
1.
28
A
do
le
sc
en
t
D
R
N
H
om
er
3
H
om
er
 h
om
ol
og
 3
3.
75
A
do
le
sc
en
t
D
R
N
M
pp
4
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 4
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 4
)
1.
68
A
do
le
sc
en
t
D
R
N
M
pp
6
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 6
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 6
)
1.
23
A
do
le
sc
en
t
D
R
N
Pd
lim
5
PD
Z 
an
d 
LI
M
 d
om
ai
n 
5
1.
28
A
do
le
sc
en
t
D
R
N
Sh
an
k1
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 1
1.
41
A
do
le
sc
en
t
D
R
N
Sh
an
k2
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 2
1.
79
A
do
le
sc
en
t
D
R
N
Sh
an
k3
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 3
1.
82
A
do
le
sc
en
t
D
R
N
Sl
c1
a3
So
lu
te
 c
ar
rie
r f
am
ily
 1
 (g
lia
l g
lut
am
ate
 tr
an
sp
ort
er)
, m
em
be
r 3
1.
70
A
do
le
sc
en
t
D
R
N
Sl
c1
a6
So
lu
te
 c
ar
rie
r f
am
ily
 1
 (g
lia
l g
lut
am
ate
 tr
an
sp
ort
er)
, m
em
be
r 6
2.
79
A
do
le
sc
en
t
D
R
N
Sl
c1
7a
7/
 V
gl
ut
1
So
lu
te
 c
ar
rie
r f
am
ily
 1
7,
 m
em
be
r 7
 (v
esi
cu
lar
 gl
uta
ma
te 
tra
ns
po
rte
r)
5.
06
A
do
le
sc
en
t
D
R
N
Sl
c2
5a
18
So
lu
te
 c
ar
rie
r f
am
ily
 2
5 
(m
ito
ch
on
dri
al 
glu
tam
ate
 ca
rri
er)
, m
em
be
r 1
8
1.
45
A
do
le
sc
en
t
D
R
N
Sl
c2
5a
22
So
lu
te
 c
ar
rie
r f
am
ily
 2
5 
(m
ito
ch
on
dri
al 
glu
tam
ate
 ca
rri
er)
, m
em
be
r 2
2
1.
30
A
do
le
sc
en
t
D
R
N
Tjp
3
Ti
gh
t ju
nc
tio
n p
rot
ein
 3 
(zo
na
 oc
clu
de
ns 
3)
2.
41
A
do
le
sc
en
t
D
R
N
M
pp
5
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 5
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 5
)
−
1.
27
A
do
le
sc
en
t
D
R
N
Sl
c1
7a
6/
 V
gl
ut
2
So
lu
te
 c
ar
rie
r f
am
ily
 1
7,
 m
em
be
r 6
 (v
esi
cu
lar
 gl
uta
ma
te 
tra
ns
po
rte
r)
−
1.
82
A
do
le
sc
en
t
D
R
N
Sl
c1
7a
8/
 V
gl
ut
3
So
lu
te
 c
ar
rie
r f
am
ily
 1
7,
 m
em
be
r 8
 (v
esi
cu
lar
 gl
uta
ma
te 
tra
ns
po
rte
r)
−
1.
97
A
do
le
sc
en
t
D
R
N
D
lg
1/
Sa
p9
7
D
isc
s, 
la
rg
e 
ho
m
ol
og
 1
 (S
ap
97
, A
M
PA
R 
tra
ffi
ck
ing
)
1.
28
A
du
lt
A
cb
Sh
D
lg
2/
Ps
d9
3
D
isc
s, 
la
rg
e 
ho
m
ol
og
 2
 (C
ha
ps
yn
-11
0/P
SD
-93
 a 
M
AG
UK
)
1.
24
A
du
lt
A
cb
Sh
G
ls2
G
lu
ta
m
in
as
e 
2
1.
40
A
du
lt
A
cb
Sh
G
lu
l
G
lu
ta
m
at
e-
am
m
on
ia
 li
ga
se
 (g
lut
am
ine
 sy
nth
ase
)
1.
14
A
du
lt
A
cb
Sh
H
om
er
1
H
om
er
 h
om
ol
og
 1
3.
49
A
du
lt
A
cb
Sh
M
pd
z
M
ul
tip
le
 P
D
Z 
do
m
ai
n 
pr
ot
ei
n
1.
22
A
du
lt
A
cb
Sh
M
pp
6
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 6
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 6
)
1.
71
A
du
lt
A
cb
Sh
Sh
an
k1
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 1
1.
26
A
du
lt
A
cb
Sh
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bell et al. Page 37
G
en
e I
D
G
en
e N
am
es
F-
C
 P
 v
s. 
N
P
F-
C
 E
 v
s. 
C
A
ge
 o
f R
at
Br
ai
n 
R
eg
io
n
Sh
an
k1
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 1
1.
19
A
du
lt
A
cb
Sh
Sh
an
k2
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 2
1.
17
A
du
lt
A
cb
Sh
Sl
c6
a9
So
lu
te
 c
ar
rie
r f
am
ily
 6
 (g
lyc
ine
 tr
an
sp
ort
er)
, m
em
be
r 9
1.
40
A
du
lt
A
cb
Sh
Sl
c7
a1
0
So
lu
te
 c
ar
rie
r f
am
ily
 7
 (g
lyc
ine
 tr
an
sp
ort
er)
, m
em
be
r 1
0 (
gli
al)
1.
42
A
du
lt
A
cb
Sh
Sl
c1
7a
6/
 V
gl
ut
2
So
lu
te
 c
ar
rie
r f
am
ily
 1
7,
 m
em
be
r 6
 (v
esi
cu
lar
 gl
uta
ma
te 
tra
ns
po
rte
r)
2.
25
A
du
lt
A
cb
Sh
Sl
c2
5a
13
/ C
itr
in
So
lu
te
 c
ar
rie
r f
am
ily
 2
5 
(m
ito
ch
on
dri
al 
glu
tam
ate
 ca
rri
er)
, m
em
be
r 1
3
1.
23
A
du
lt
A
cb
Sh
D
lg
1/
Sa
p9
7
D
isc
s, 
la
rg
e 
ho
m
ol
og
 1
 (S
ap
97
, A
M
PA
R 
tra
ffi
ck
ing
)
−
1.
09
A
du
lt
A
cb
Sh
D
lg
2/
Ps
d9
3
D
isc
s, 
la
rg
e 
ho
m
ol
og
 2
 (C
ha
ps
yn
-11
0/P
SD
-93
 a 
M
AG
UK
)
−
1.
17
A
du
lt
A
cb
Sh
D
lg
2/
Ps
d9
3
D
isc
s, 
la
rg
e 
ho
m
ol
og
 2
 (C
ha
ps
yn
-11
0/P
SD
-93
 a 
M
AG
UK
)
−
1.
38
A
du
lt
A
cb
Sh
D
lg
4/
Ps
d9
5
D
isc
s, 
la
rg
e 
ho
m
ol
og
 4
 (P
SD
95
 or
 Sa
p9
0)
−
1.
25
A
du
lt
A
cb
Sh
G
ls
G
lu
ta
m
in
as
e
−
1.
35
A
du
lt
A
cb
Sh
H
om
er
1
H
om
er
 h
om
ol
og
 1
−
1.
68
A
du
lt
A
cb
Sh
M
pp
4
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 4
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 4
)
−
1.
08
A
du
lt
A
cb
Sh
M
pp
7
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 7
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 7
)
−
1.
58
A
du
lt
A
cb
Sh
Pd
lim
7
PD
Z 
an
d 
LI
M
 d
om
ai
n 
7
−
1.
25
A
du
lt
A
cb
Sh
Sh
an
k1
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 1
−
1.
14
A
du
lt
A
cb
Sh
Sh
an
k2
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 2
−
1.
22
A
du
lt
A
cb
Sh
Sh
an
k3
SH
3 
an
d 
m
ul
tip
le
 a
nk
yr
in
 re
pe
at
 d
om
ai
ns
 3
−
1.
30
A
du
lt
A
cb
Sh
Sl
c1
a3
So
lu
te
 c
ar
rie
r f
am
ily
 1
 (g
lia
l g
lut
am
ate
 tr
an
sp
ort
er)
, m
em
be
r 3
−
1.
30
A
du
lt
A
cb
Sh
Ca
sk
Ca
lc
iu
m
/c
al
m
od
ul
in
-d
ep
en
de
nt
 se
rin
e 
pr
ot
ei
n 
ki
na
se
 (M
AG
UK
 fa
mi
ly)
1.
14
A
du
lt
Ce
A
H
om
er
1
H
om
er
 h
om
ol
og
 1
2.
19
A
du
lt
Ce
A
Pd
lim
3
PD
Z 
an
d 
LI
M
 d
om
ai
n 
3
1.
28
A
du
lt
Ce
A
Sl
c2
5a
22
So
lu
te
 c
ar
rie
r f
am
ily
 2
5 
(m
ito
ch
on
dri
al 
glu
tam
ate
 ca
rri
er)
, m
em
be
r 2
2
1.
12
A
du
lt
Ce
A
G
ls2
G
lu
ta
m
in
as
e 
2
−
1.
17
A
du
lt
Ce
A
H
om
er
2
H
om
er
 h
om
ol
og
 2
−
1.
16
A
du
lt
Ce
A
M
pp
3
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 3
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 3
)
−
1.
45
A
du
lt
Ce
A
Tg
m
2
Tr
an
sg
lu
ta
m
in
as
e 
2,
 C
 p
ol
yp
ep
tid
e
−
1.
30
A
du
lt
Ce
A
G
lu
l
G
lu
ta
m
at
e-
am
m
on
ia
 li
ga
se
 (g
lut
am
ine
 sy
nth
eta
se)
1.
08
A
du
lt
V
TA
D
lg
2/
Ps
d9
3
D
isc
s, 
la
rg
e 
ho
m
ol
og
 2
 (C
ha
ps
yn
-11
0/P
SD
-93
 a 
M
AG
UK
)
−
1.
17
A
du
lt
V
TA
M
pp
6
M
em
br
an
e 
pr
ot
ei
n,
 p
al
m
ito
yl
at
ed
 6
 (M
AG
UK
 p5
5 s
ub
fam
ily
 m
em
be
r 6
)
−
1.
10
A
du
lt
V
TA
Pd
lim
7
PD
Z 
an
d 
LI
M
 d
om
ai
n 
7
−
1.
12
A
du
lt
V
TA
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bell et al. Page 38
G
en
e I
D
G
en
e N
am
es
F-
C
 P
 v
s. 
N
P
F-
C
 E
 v
s. 
C
A
ge
 o
f R
at
Br
ai
n 
R
eg
io
n
Tg
m
2
Tr
an
sg
lu
ta
m
in
as
e 
2,
 C
 p
ol
yp
ep
tid
e
−
1.
38
A
du
lt
V
TA
A
ge
 o
f r
at
 re
fe
rs
 to
 w
he
th
er
 th
e 
P 
ra
ts 
ha
d 
ac
ce
ss
 to
 e
th
an
ol
 d
ur
in
g 
(pe
ri-
)ad
ole
sce
nc
e (
PN
Ds
, 3
0–
50
) o
r d
uri
ng
 ad
ult
ho
od
>P
ND
75
. B
rai
n r
eg
ion
s p
ub
lis
he
d t
hu
s f
ar:
 C
eA
, D
RN
, A
cb
Sh
, a
nd
 V
TA
. T
o 
fa
ci
lit
at
e 
di
sti
nc
tio
n 
be
tw
ee
n 
di
re
ct
io
ns
 o
f e
xp
re
ss
io
n 
(e.
g.,
 up
- v
s. 
do
wn
reg
ula
tio
n),
 do
wn
reg
ula
tio
n o
r l
ow
er 
lev
el 
F-
Cs
 ar
e i
n i
tal
ics
 an
d a
re 
be
low
 th
e f
ind
ing
s o
f u
pre
gu
lat
ion
 or
 hi
gh
er-
lev
el 
F-
Cs
 fo
r t
ha
t 
ag
e 
an
d 
br
ai
n 
re
gi
on
.
Prog Mol Biol Transl Sci. Author manuscript; available in PMC 2017 January 01.
